Literature DB >> 27964920

Intraoperative Near-Infrared Fluorescence Imaging of Thymus in Preclinical Models.

Hideyuki Wada1, Hoon Hyun2, Homan Kang3, Julien Gravier3, Maged Henary4, Mark W Bordo5, Hak Soo Choi3, John V Frangioni6.   

Abstract

BACKGROUND: There are currently no thymus-specific contrast agents for biomedical imaging. Thus, finding ectopic thymic tissue during certain operations is extremely difficult. The purpose of the present study was to determine if near-infrared (NIR) fluorescence imaging could provide high sensitivity, real-time identification of thymic tissue during the operation.
METHODS: After initial in vivo screening of a 315-compound NIR fluorophore library for thymic uptake, methylene blue and five different 700-nm emitting candidate molecules were injected into CD-1 mice for quantitation of the signal-to-background ratio as a function of kinetics and dosing. Results were confirmed in 35-kg Yorkshire pigs. Dual-channel NIR imaging was also performed using a variety of 800-nm emitting NIR fluorophores targeted to various tissues in the mediastinum and neck.
RESULTS: The compound Oxazine 170 demonstrated the highest signal-to-background ratio (≥3) for thymic tissue relative to mediastinal fat, heart, lung, muscle, thyroid gland, and parathyroid gland, with peak signal-to-background ratio occurring 4 h after 1 intravenous injection of a human equivalent dose of approximately 7 mg. Simultaneous dual-channel NIR imaging permitted unambiguous identification of the thymus from surrounding tissues, such as endocrine glands and lymph nodes.
CONCLUSIONS: In mouse and pig, NIR fluorescence imaging using Oxazine 170 permits high sensitivity, real-time identification of thymic tissue for surgical procedures requiring its resection or avoidance. The performance of Oxazine 170 for imaging human thymic tissue is currently not known.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27964920      PMCID: PMC5376245          DOI: 10.1016/j.athoracsur.2016.09.050

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  30 in total

1.  Distribution of thymic tissue at the anterior mediastinum. Current procedures in thymectomy.

Authors:  A Masaoka; Y Nagaoka; Y Kotake
Journal:  J Thorac Cardiovasc Surg       Date:  1975-10       Impact factor: 5.209

2.  "Maximal" thymectomy for myasthenia gravis. Results.

Authors:  A Jaretzki; A S Penn; D S Younger; M Wolff; M R Olarte; R E Lovelace; L P Rowland
Journal:  J Thorac Cardiovasc Surg       Date:  1988-05       Impact factor: 5.209

3.  Inclusion of the transcervical approach in video-assisted thoracoscopic extended thymectomy (VATET) for myasthenia gravis: a prospective trial.

Authors:  N Shigemura; H Shiono; M Inoue; M Minami; M Ohta; M Okumura; H Matsuda
Journal:  Surg Endosc       Date:  2006-06-22       Impact factor: 4.584

Review 4.  MRI of the thymus.

Authors:  Jeanne B Ackman; Carol C Wu
Journal:  AJR Am J Roentgenol       Date:  2011-07       Impact factor: 3.959

Review 5.  Clinical and radiologic review of the normal and abnormal thymus: pearls and pitfalls.

Authors:  Farbod Nasseri; Farzin Eftekhari
Journal:  Radiographics       Date:  2010-03       Impact factor: 5.333

6.  Predictors of outcome in thymectomy for myasthenia gravis.

Authors:  J M Budde; C D Morris; A A Gal; K A Mansour; J I Miller
Journal:  Ann Thorac Surg       Date:  2001-07       Impact factor: 4.330

7.  Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomes.

Authors:  Marlies Keijzers; Marc de Baets; Monique Hochstenbag; Myrurgia Abdul-Hamid; Axel Zur Hausen; Marcel van der Linden; Jan Kuks; Jan Verschuuren; Fons Kessels; Anne-Marie C Dingemans; Jos Maessen
Journal:  Eur J Cardiothorac Surg       Date:  2014-09-18       Impact factor: 4.191

8.  Modified maximal thymectomy for myasthenia gravis: effect of maximal resection on late neurologic outcome and predictors of disease remission.

Authors:  Christos Prokakis; Efstratios Koletsis; Stavroula Salakou; Efstratios Apostolakis; Nikolaos Baltayiannis; Antonios Chatzimichalis; Theodoros Papapetropoulos; Dimitrios Dougenis
Journal:  Ann Thorac Surg       Date:  2009-11       Impact factor: 4.330

9.  The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping.

Authors:  Susan L Troyan; Vida Kianzad; Summer L Gibbs-Strauss; Sylvain Gioux; Aya Matsui; Rafiou Oketokoun; Long Ngo; Ali Khamene; Fred Azar; John V Frangioni
Journal:  Ann Surg Oncol       Date:  2009-07-07       Impact factor: 5.344

10.  Structure-inherent targeting of near-infrared fluorophores for parathyroid and thyroid gland imaging.

Authors:  Hoon Hyun; Min Ho Park; Eric A Owens; Hideyuki Wada; Maged Henary; Henricus J M Handgraaf; Alexander L Vahrmeijer; John V Frangioni; Hak Soo Choi
Journal:  Nat Med       Date:  2015-01-05       Impact factor: 53.440

View more
  2 in total

1.  It's not always too late: a case for minimally invasive salvage esophagectomy.

Authors:  Ryan C Broderick; Arielle M Lee; Rachel R Blitzer; Beiqun Zhao; Jenny Lam; Joslin N Cheverie; Bryan J Sandler; Garth R Jacobsen; Mark W Onaitis; Kaitlyn J Kelly; Michael Bouvet; Santiago Horgan
Journal:  Surg Endosc       Date:  2020-09-17       Impact factor: 4.584

2.  Real-Time Fluorescence Imaging in Thoracic Surgery.

Authors:  Priyanka Das; Sheena Santos; G Kate Park; I Hoseok; Hak Soo Choi
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2019-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.